First-time prescribing of ADMs decreased slightly in March 2025 relative to December (-6.56%), while first-time prescribing of AOMs increased from December 2024 to January 2025, before remaining relatively stable until March 2025 (+18.63%)
If you're wondering whether TRT is making things worse instead of better, you're not alone, and what you're ex
The Ivim Health Approach: GLP-1 ID for Individualized Results Understanding the differences between tirzepatide and semaglutide is just the beginning
IV Therapy allows us to achieve maximum effect, working at a faster and more effective rate, delivering directly to the cells
This is the part that has generated the most excitement, and it deserves a careful, honest look
SEE IF TIRZEPATIDE IS RIGHT FOR YOU The Bottom Line Tirzepatide may lower blood pressure, especially systolic blood pressure, in some adults with obesity or excess weight